This World TB Day, we are celebrating the success of TB PRACTECAL, a clinical trial led by Médecins Sans Frontières / Doctors Without Borders (MSF). TB PRACTECAL has found a new all-oral six-month treatment regimen to be safer and more effective at treating rifampicin-resistant tuberculosis (RR-TB) than the current accepted standard of care.
Médecins Sans Frontières (MSF) is an international, independent, medical humanitarian organisation that delivers emergency aid to people affected by armed conflict, epidemics, natural disasters and exclusion from healthcare.
SUBSCRIBE HERE: [ Ссылка ]
